PCMRX
Price
$24.51
Change
-$0.10 (-0.41%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

PCMRX vs VMVAX

Header iconPCMRX vs VMVAX Comparison
Open Charts PCMRX vs VMVAXBanner chart's image
Pioneer Mid Cap Value R
Price$24.51
Change-$0.10 (-0.41%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PCMRX vs VMVAX Comparison Chart
Loading...
VS
PCMRX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCMRX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. PCMRX (740M). VMVAX pays higher dividends than PCMRX: VMVAX (2.14) vs PCMRX (1.12). PCMRX was incepted earlier than VMVAX: PCMRX (21 years) vs VMVAX (13 years). PCMRX is a more actively managed with annual turnover of: 45.00 vs. VMVAX (22.00). PCMRX has a lower initial minimum investment than VMVAX: PCMRX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. PCMRX (14.38). VMVAX return over 5 years is better than : 48.82 vs. PCMRX (17.14).
PCMRXVMVAXPCMRX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years13 years-
Gain YTD10.06314.94667%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets740M30.5B2%
Annual Yield % from dividends1.122.1453%
Returns for 1 year14.3825.3557%
Returns for 3 years-5.3720.71-26%
Returns for 5 years17.1448.8235%
Returns for 10 years-7.70100.88-8%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio